We measured plasma tau protein levels and the levels of circulating atherosclerosis-related inflammatory mediators in patients with PSP and in the control group, in order to explore potential links between tau and vascular inflammatory pathways. Here, MAPT is linked to supranuclear palsy, progressive, 1.